(1)
Shinta, D. W.; Khotib, J.; Rahardjo, E.; Rahmadi, M.; Suprapti, B. THE USE OF HYDROXYETHYL STARCH 200/0,5 AS PLASMA SUBTITUTES IS SAFE IN HYPOVOLEMIC PATIENTS AS INDICATED IN CHANGES OF N-ACETYL--GLUCOSAMINIDASE AND CREATININ SERUM PARAMETERS. FMI 2015, 51, 228-233.